Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Firefly Neuroscience (AIFF) Accumulated Depreciation (2018 - 2025)

Firefly Neuroscience has reported Accumulated Depreciation over the past 7 years, most recently at $58000.0 for Q4 2025.

  • Quarterly results put Accumulated Depreciation at $58000.0 for Q4 2025, up 383.33% from a year ago — trailing twelve months through Dec 2025 was $58000.0 (up 383.33% YoY), and the annual figure for FY2025 was $58000.0, up 383.33%.
  • Accumulated Depreciation for Q4 2025 was $58000.0 at Firefly Neuroscience, up from $31000.0 in the prior quarter.
  • Over the last five years, Accumulated Depreciation for AIFF hit a ceiling of $391628.0 in Q4 2022 and a floor of $8000.0 in Q3 2024.
  • Median Accumulated Depreciation over the past 4 years was $31000.0 (2025), compared with a mean of $124216.3.
  • Biggest five-year swings in Accumulated Depreciation: grew 11.39% in 2021 and later soared 383.33% in 2025.
  • Firefly Neuroscience's Accumulated Depreciation stood at $347886.0 in 2021, then grew by 12.57% to $391628.0 in 2022, then plummeted by 96.94% to $12000.0 in 2024, then soared by 383.33% to $58000.0 in 2025.
  • The last three reported values for Accumulated Depreciation were $58000.0 (Q4 2025), $31000.0 (Q2 2025), and $21000.0 (Q1 2025) per Business Quant data.